United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2017_register
executive
2017-03-14
article
Enhancing Patient Engagement Efforts Across the Food and Drug Administration; Establishment of a Public Docket; Request for Comments
Notices
D09002ee1bdbed8aa
D09002ee1bdbedd53
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA or Agency) is establishing a public docket to solicit input on ongoing efforts to enhance mechanisms for patient engagement at the Agency. Engaging with patients, their caregivers, and advocates has long been a priority of the Agency. In this tradition, FDA intends to enhance future patient engagement by providing a more transparent, accessible, and robust experience for patient communities. To achieve these goals, FDA is considering establishing a new Office of Patient Affairs. This concept was directly informed by the public feedback solicited through the prior public docket regarding FDA's stakeholder engagement responsibilities outlined by the Food and Drug Administration Safety and Innovation Act (FDASIA). The purpose of this notice is to outline FDA's proposal for the future of patient engagement at the Agency so that the perspectives of patient communities can be better captured.
82 FR 13632
https://www.govinfo.gov/app/details/FR-2017-03-14/2017-04982
2017-04982
fr14mr17-41
4164-01-P
Docket No. FDA-2017-N-0455
https://www.govinfo.gov/app/details/FR-2017-03-14/2017-04982
https://www.govinfo.gov/content/pkg/FR-2017-03-14/html/2017-04982.htm
https://www.govinfo.gov/content/pkg/FR-2017-03-14/pdf/2017-04982.pdf
3 p.
13632
13634
82 FR 13632
Enhancing Patient Engagement Efforts Across the Food and Drug Administration; Establishment of a Public Docket; Request for Comments; Federal Register Vol. 82, Issue
NOTICE
2017-04982
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2017-06-12
Docket No. FDA-2017-N-0455
4164-01-P
2017-04982
Notice; request for comments.
The Food and Drug Administration (FDA or Agency) is establishing a public docket to solicit input on ongoing efforts to enhance mechanisms for patient engagement at the Agency. Engaging with patients, their caregivers, and advocates has long been a priority of the Agency. In this tradition, FDA intends to enhance future patient engagement by providing a more transparent, accessible, and robust experience for patient communities. To achieve these goals, FDA is considering establishing a new Office of Patient Affairs. This concept was directly informed by the public feedback solicited through the prior public docket regarding FDA's stakeholder engagement responsibilities outlined by the Food and Drug Administration Safety and Innovation Act (FDASIA). The purpose of this notice is to outline FDA's proposal for the future of patient engagement at the Agency so that the perspectives of patient communities can be better captured.
Submit either electronic or written comments by June 12, 2017.
Sharnell Ligon, Office of Medical Products and Tobacco, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 6125, Silver Spring, MD 20993, 301-796-5253, FAX: 301-847-3532.
Enhancing Patient Engagement Efforts Across the Food and Drug Administration
,
http://www.fda.gov/regulatoryinformation/dockets/default.htm
https://www.regulations.gov
Federal Register
Vol. 82, no. 48
Office of the Federal Register, National Archives and Records Administration
2017-03-14
continuing
daily
deposited
born digital
202 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2017-03-14
P0b002ee193f8ff8a
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr14mr17
https://www.govinfo.gov/app/details/FR-2017-03-14
https://www.govinfo.gov/content/pkg/FR-2017-03-14/pdf/FR-2017-03-14.pdf
https://www.govinfo.gov/content/pkg/FR-2017-03-14/xml/FR-2017-03-14.xml
fdlp
13549
13740
DGPO
2017-03-14
2023-04-28
FR-2017-03-14
machine generated
eng
FR
FR-2017-03-14
82
48